Cargando…
Voting behavior during FDA Medical Device Advisory Committee panel meetings
OBJECTIVES: During premarket review, the US Food and Drug Administration may ask its Medical Device Advisory Committee (MDAC) Panels to assess the safety and effectiveness of medical devices being considered for approval. The objective of this study is to assess the relationship, if any, between ind...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231736/ https://www.ncbi.nlm.nih.gov/pubmed/35749461 http://dx.doi.org/10.1371/journal.pone.0267134 |
_version_ | 1784735410982748160 |
---|---|
author | Maisel-Campbell, Amanda Schlessinger, Daniel I. Yanes, Arianna F. Veledar, Emir Reynolds, Kelly A. Ibrahim, Sarah A. Kang, Bianca Y. Anvery, Noor Poon, Emily Alam, Murad |
author_facet | Maisel-Campbell, Amanda Schlessinger, Daniel I. Yanes, Arianna F. Veledar, Emir Reynolds, Kelly A. Ibrahim, Sarah A. Kang, Bianca Y. Anvery, Noor Poon, Emily Alam, Murad |
author_sort | Maisel-Campbell, Amanda |
collection | PubMed |
description | OBJECTIVES: During premarket review, the US Food and Drug Administration may ask its Medical Device Advisory Committee (MDAC) Panels to assess the safety and effectiveness of medical devices being considered for approval. The objective of this study is to assess the relationship, if any, between individual votes and Panel recommendations and: (1) the composition of Panels, specifically the expertise and demographic features of individual members; or (2) Panel members’ propensity to speak during Panel deliberations. METHODS: This was a retrospective cohort study of routinely collected data from voting members of MDAC panels convened between January 2011 to June 2016 to consider premarket approval. Data sources were verbatim transcripts available publicly from the FDA. Number of words spoken, directionality of votes on device approval, profession, and demographics were collected. RESULTS: 658,954 words spoken by 536 members during 49 meetings of 11 Panels were analyzed. Based on multivariate analysis, biostatisticians spoke more (+373 words; P = 0.0002), and women (-187 words; P = 0.0184) and other non-physician voting members less (-213 words; P = 0.0306), than physicians. Speaking more was associated with abstaining (P = 0.0179), and with voting against the majority (P = 0.0153). Non-physician, non-biostatistician members (P = 0.0109), and those having attended more meetings as a voting member (P = 0.0249) were more likely to vote against approval. In bivariable analysis, unanimous Panels had a greater proportion of biostatisticians (mean 0.1580; 95% CI 0.1237–0.1923) than non-unanimous Panels (0.1107; 95% CI 0.0912–0.1301; p = 0.0201). CONCLUSIONS: Panelists likely to vote against the majority include non-physician, non-biostatisticians; experienced Panelists; and more talkative members. The increased presence of biostatisticians on Panels leads to greater voting consensus. Having a diversity of opinions on Panels, including in sufficient numbers those members likely to dissent from majority views, may help ensure that a diversity of opinions are aired before decision-making. |
format | Online Article Text |
id | pubmed-9231736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-92317362022-06-25 Voting behavior during FDA Medical Device Advisory Committee panel meetings Maisel-Campbell, Amanda Schlessinger, Daniel I. Yanes, Arianna F. Veledar, Emir Reynolds, Kelly A. Ibrahim, Sarah A. Kang, Bianca Y. Anvery, Noor Poon, Emily Alam, Murad PLoS One Research Article OBJECTIVES: During premarket review, the US Food and Drug Administration may ask its Medical Device Advisory Committee (MDAC) Panels to assess the safety and effectiveness of medical devices being considered for approval. The objective of this study is to assess the relationship, if any, between individual votes and Panel recommendations and: (1) the composition of Panels, specifically the expertise and demographic features of individual members; or (2) Panel members’ propensity to speak during Panel deliberations. METHODS: This was a retrospective cohort study of routinely collected data from voting members of MDAC panels convened between January 2011 to June 2016 to consider premarket approval. Data sources were verbatim transcripts available publicly from the FDA. Number of words spoken, directionality of votes on device approval, profession, and demographics were collected. RESULTS: 658,954 words spoken by 536 members during 49 meetings of 11 Panels were analyzed. Based on multivariate analysis, biostatisticians spoke more (+373 words; P = 0.0002), and women (-187 words; P = 0.0184) and other non-physician voting members less (-213 words; P = 0.0306), than physicians. Speaking more was associated with abstaining (P = 0.0179), and with voting against the majority (P = 0.0153). Non-physician, non-biostatistician members (P = 0.0109), and those having attended more meetings as a voting member (P = 0.0249) were more likely to vote against approval. In bivariable analysis, unanimous Panels had a greater proportion of biostatisticians (mean 0.1580; 95% CI 0.1237–0.1923) than non-unanimous Panels (0.1107; 95% CI 0.0912–0.1301; p = 0.0201). CONCLUSIONS: Panelists likely to vote against the majority include non-physician, non-biostatisticians; experienced Panelists; and more talkative members. The increased presence of biostatisticians on Panels leads to greater voting consensus. Having a diversity of opinions on Panels, including in sufficient numbers those members likely to dissent from majority views, may help ensure that a diversity of opinions are aired before decision-making. Public Library of Science 2022-06-24 /pmc/articles/PMC9231736/ /pubmed/35749461 http://dx.doi.org/10.1371/journal.pone.0267134 Text en © 2022 Maisel-Campbell et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Maisel-Campbell, Amanda Schlessinger, Daniel I. Yanes, Arianna F. Veledar, Emir Reynolds, Kelly A. Ibrahim, Sarah A. Kang, Bianca Y. Anvery, Noor Poon, Emily Alam, Murad Voting behavior during FDA Medical Device Advisory Committee panel meetings |
title | Voting behavior during FDA Medical Device Advisory Committee panel meetings |
title_full | Voting behavior during FDA Medical Device Advisory Committee panel meetings |
title_fullStr | Voting behavior during FDA Medical Device Advisory Committee panel meetings |
title_full_unstemmed | Voting behavior during FDA Medical Device Advisory Committee panel meetings |
title_short | Voting behavior during FDA Medical Device Advisory Committee panel meetings |
title_sort | voting behavior during fda medical device advisory committee panel meetings |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231736/ https://www.ncbi.nlm.nih.gov/pubmed/35749461 http://dx.doi.org/10.1371/journal.pone.0267134 |
work_keys_str_mv | AT maiselcampbellamanda votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings AT schlessingerdanieli votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings AT yanesariannaf votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings AT veledaremir votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings AT reynoldskellya votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings AT ibrahimsaraha votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings AT kangbiancay votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings AT anverynoor votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings AT poonemily votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings AT alammurad votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings |